First-Line Therapy for Helicobacter pylori Infection
Bismuth quadruple therapy (BQT) for 14 days is the recommended first-line treatment for H. pylori infection when antibiotic susceptibility is unknown. 1
Recommended First-Line Regimen: Bismuth Quadruple Therapy
The optimal BQT consists of 2, 3:
- Proton pump inhibitor (PPI): Esomeprazole 20-40 mg OR rabeprazole 20-40 mg twice daily, 30 minutes before meals (avoid pantoprazole due to lower potency)
- Bismuth: 2 tablets or capsules four times daily, 30 minutes before meals (e.g., Pepto-Bismol® 262 mg tablets)
- Tetracycline: 500 mg four times daily, 30 minutes after meals
- Metronidazole: 500 mg four times daily, 30 minutes after meals
- Duration: 14 days
Key Advantages of BQT
BQT maintains high efficacy (>90% eradication rates) even in the presence of metronidazole resistance, which is critical since metronidazole resistance rates can exceed 45% 4. The combination of bismuth with metronidazole creates a synergistic effect that overcomes resistance 3. This regimen is endorsed by all major guidelines (ACG, Maastricht V/Florence, Toronto Consensus) as first-line therapy 3, 1.
Alternative First-Line Regimens
When Bismuth is Unavailable
If bismuth is not accessible, rifabutin triple therapy for 14 days is the preferred alternative 1:
- Rifabutin: 150 mg twice daily
- Amoxicillin: 1 g three times daily
- High-dose PPI: Esomeprazole or rabeprazole 40 mg twice daily, 30 minutes before meals
The rifabutin regimen has the theoretical advantage of rare resistance and shows encouraging clinical results 2. Generic rifabutin costs approximately $150 with discount coupons in the United States, while the branded formulation (Talicia®) costs around $700 2.
For Penicillin Allergy
In patients with true penicillin allergy, BQT remains the treatment of choice 3. If bismuth is unavailable AND the patient has penicillin allergy, clarithromycin-based triple therapy with metronidazole can be considered only in areas with clarithromycin resistance <15% 5.
Practical Considerations
Cost and Formulations
- Pylera® (combination BQT capsule): Costs >$1,000 in the US but ~€70 in Europe; packaged for 10 days only 2
- Generic components: More cost-effective; tetracycline can be obtained for <$100 with discount coupons (retail ~$660) 2
- Do NOT substitute doxycycline for tetracycline - results are significantly inferior 2
PPI Selection
Higher-potency PPIs are critical for success, particularly with amoxicillin-containing regimens 2:
- Preferred: Esomeprazole 20-40 mg or rabeprazole 20-40 mg twice daily
- Avoid: Pantoprazole (40 mg pantoprazole = only 9 mg omeprazole equivalent)
- Acceptable: Lansoprazole 30-45 mg or omeprazole 40 mg twice daily
Follow-Up Testing to Confirm Eradication
Universal post-treatment test-of-cure is recommended 1. Testing should be performed:
- Timing: 4-8 weeks after completion of eradication therapy 6
- Preferred method: Urea breath test (UBT) 3, 7
- Alternative: Stool antigen test if UBT unavailable 7
- Endoscopy-based test: Only if endoscopy is clinically indicated 7
Critical Pitfall
Ensure patients are off PPIs for at least 2 weeks before testing to avoid false-negative results (though this specific timing is based on general medical knowledge, as the provided evidence doesn't explicitly state the PPI washout period).
Treatment Duration
14 days is the preferred duration for all first-line therapies 3, 1. While some guidelines list 10-14 days as acceptable for BQT, the consensus favors 14 days to maximize eradication success on the first attempt 3. Recent evidence suggests 10-day BQT may achieve comparable rates with better tolerability 8, but 14 days remains the standard recommendation.
Obsolete Regimens to Avoid
The following regimens are no longer recommended as they include antibiotics that provide no therapeutic benefit and only increase antimicrobial resistance 2:
- Concomitant therapy
- Sequential therapy
- Hybrid therapy
- Reverse hybrid therapy